This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: C.R. Bard, Gap, GNC, Medtronic, Tyson Foods

Stocks in this article: BCR WAG TSN GPS MDT


Ambit Biosciences (AMBI) was initiated with a sell rating at TheStreet Ratings.

Gap (GPS) was upgraded at Canaccord Genuity to buy from hold. Twelve-month price target is $51. Company can continue to expand margins, Canaccord Genuity said.

C.R. Bard (BCR) was downgraded at Barclays to equal weight from overweight. Pressure on company due to its exposure to the peripheral vascular space, which is affected by Medtronic (MDT)/Covidien (COV) deal, Barclays said.

Franklin Resources (BEN) was upgraded at Goldman Sachs to buy from neutral. Better flow trends are being driven by emerging markets, and recent underperformance offers a cheap entry point, Goldman said.

GNC (GNC) was downgraded at J.P. Morgan to neutral. Company is seeing slower sales trends, and the CFO has left, J.P. Morgan said.

Gap (GPS) was upgraded at Canaccord Genuity to buy from hold. Twelve-month price target is $51. Company can continue to expand margins, Canaccord Genuity said.

Medtronic was upgraded at Barclays to overweight from equal weight. Driven by potential benefits from acquisition of Covidien, Barclays said. Twelve-month price target is $73.

North European Oil Royalty Trust (NRT) was downgraded to hold at TheStreet Ratings.

Sunpower (SPWR) was downgraded at J.P. Morgan to neutral. Valuation call, as the stock is up 35% year to date, J.P. Morgan said. Twelve-month price target is $40.

Tyson Foods (TSN) upgraded at BMO Capital to outperform. Higher margins create opportunities for realized earnings potential in Hillshire and accelerated repaying of debts, BMO Capital said. Twelve-month price target is $43.

Walgreen (WAG) was upgraded at Barclays to overweight from equal weight. Driven by reducing expenses and optimizing capital structure, Barclays said. Twelve-month price target is $92.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

Citigroup Looks Like a Smart Hedge as Interest Rates Remain Low

United Leads in China, but American and Delta Want Bigger Shares

This article was written by a staff member of TheStreet.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs